Bank of America upgraded P to Buy today, raising its target 67% to $150. That is the single biggest rating move in a wave of post-earnings analyst actions that has reshaped the consensus overnight.
The upgrade wave is the standout. It resolves a tension that the previous convergence report flagged: analysts were raising targets but staying cautious on ratings. That caution is now gone, at least at B of A.
Wamsi Mohan at B of A Securities lifted his target from $90 to $150 and moved from Neutral to Buy. That followed a busy morning of raises. JP Morgan's Samik Chatterjee went to $145 from $130. Piper Sandler moved to $133 from $92. Wells Fargo raised to $135 from $97. Needham went to $140 from $100.
The consensus mean now stands at $128.37. The stock closed at $108.90 on August 26. That implies roughly 18% upside to the average target — the first time in weeks the Street has been meaningfully ahead of the tape rather than marking to market.
Thirteen analysts now rate P a Buy. One holds. UBS remains the lone Sell, raising its target to $80 from $70 — moving in the right direction but still deeply detached from the pack.
The analyst-recommendation divergence factor sits at a percentile rank of 100. That is the ceiling.
Options positioning remains defensive. The put-call ratio is 0.80, sitting 2.1 standard deviations above the 20-day mean of 0.71. It briefly hit 0.83 on August 25 — the 52-week high.
That divergence — analysts uniformly bullish, options traders loading up on downside protection — was the core tension in the prior note. The B of A upgrade has not resolved it. If anything, the gap has widened.
The lending market offers no support for the bear case. Borrow availability is effectively unlimited, with 218 million shares available against roughly 8.8 million shorted. Short interest sits at 2.68% of free float, down 13% over the past week and 14.6% over the past month. Cost to borrow has collapsed 62% in one week to 0.14%. There is no squeeze pressure here — shorts are exiting into strength, not getting trapped.
One data point cuts against the bullish re-rating. Founder John Colgrove sold shares across August 13 and 14, trimming 789,720 shares from his position — worth roughly $18 million at then-current prices. He remains the sixth-largest holder with a 3.4% stake. His selling has been consistent with the rally, not a reaction against it, but the divergence from analyst enthusiasm is worth noting.
What to watch: Whether the options put overhang fades now that B of A has formally joined the bull camp — or whether elevated PCR levels persist as a hedge against a stock that has already moved 46% in a month.
See the live data behind this article on ORTEX.
Open P on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
